ES2180689T3 - Linea inmortalizada de celulas epiteliales del colon humano. - Google Patents
Linea inmortalizada de celulas epiteliales del colon humano.Info
- Publication number
- ES2180689T3 ES2180689T3 ES96201064T ES96201064T ES2180689T3 ES 2180689 T3 ES2180689 T3 ES 2180689T3 ES 96201064 T ES96201064 T ES 96201064T ES 96201064 T ES96201064 T ES 96201064T ES 2180689 T3 ES2180689 T3 ES 2180689T3
- Authority
- ES
- Spain
- Prior art keywords
- cells
- agent
- epitelial
- human colon
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000001072 colon Anatomy 0.000 title abstract 4
- 210000002919 epithelial cell Anatomy 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 230000000694 effects Effects 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 230000002503 metabolic effect Effects 0.000 abstract 2
- 230000004060 metabolic process Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000003471 mutagenic agent Substances 0.000 abstract 2
- 231100000707 mutagenic chemical Toxicity 0.000 abstract 2
- 230000003505 mutagenic effect Effects 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003086 colorant Substances 0.000 abstract 1
- 238000004690 coupled electron pair approximation Methods 0.000 abstract 1
- 230000001955 cumulated effect Effects 0.000 abstract 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 238000009413 insulation Methods 0.000 abstract 1
- 229930002330 retinoic acid Natural products 0.000 abstract 1
- 229960001727 tretinoin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201064A EP0802257B1 (fr) | 1996-04-19 | 1996-04-19 | Lignée immortalisée de cellules épithéliales du colon humain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2180689T3 true ES2180689T3 (es) | 2003-02-16 |
Family
ID=8223895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96201064T Expired - Lifetime ES2180689T3 (es) | 1996-04-19 | 1996-04-19 | Linea inmortalizada de celulas epiteliales del colon humano. |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US6194203B1 (pt) |
| EP (1) | EP0802257B1 (pt) |
| JP (1) | JP3931212B2 (pt) |
| AT (1) | ATE222598T1 (pt) |
| AU (1) | AU733913B2 (pt) |
| CA (1) | CA2202923C (pt) |
| DE (1) | DE69623109T2 (pt) |
| DK (1) | DK0802257T3 (pt) |
| ES (1) | ES2180689T3 (pt) |
| FI (1) | FI120352B (pt) |
| NO (1) | NO319494B1 (pt) |
| NZ (1) | NZ314614A (pt) |
| PT (1) | PT802257E (pt) |
| RU (1) | RU2220201C2 (pt) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0802257B1 (fr) * | 1996-04-19 | 2002-08-21 | Societe Des Produits Nestle S.A. | Lignée immortalisée de cellules épithéliales du colon humain |
| DE69636755T2 (de) | 1996-12-24 | 2007-10-11 | Société des Produits Nestlé S.A. | Immortalisierte menschliche Epithelzell-Linie |
| US5960073A (en) * | 1997-04-03 | 1999-09-28 | Genesys Telecommunications Laboratories , Inc. | Method and apparatus for providing an interactive home agent with access to call center functionality and resources |
| DE19755023C2 (de) * | 1997-12-11 | 2000-03-09 | Celanese Chem Europe Gmbh | Katalysator und Verfahren zur Herstellung von Vinylacetat |
| EP1048724A1 (en) * | 1999-04-27 | 2000-11-02 | Transgene S.A. | Human myoblast cell lines and their uses |
| EP1048725B1 (en) * | 1999-04-27 | 2005-07-06 | Transgene S.A. | Process for production of mammalian cell lines |
| US7078232B2 (en) * | 1999-08-19 | 2006-07-18 | Artecel, Inc. | Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof |
| US6429013B1 (en) * | 1999-08-19 | 2002-08-06 | Artecel Science, Inc. | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| US6416999B1 (en) * | 2000-04-07 | 2002-07-09 | Raven Biotechnologies, Inc. | Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
| WO2002066603A2 (en) * | 2001-02-15 | 2002-08-29 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| CA2479072A1 (en) * | 2002-03-12 | 2003-12-18 | Surface Logix, Inc. | Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound |
| GB0212405D0 (en) * | 2002-05-29 | 2002-07-10 | Insignion Holdings Ltd | Composition and its therapeutic use |
| US7115563B2 (en) * | 2002-05-29 | 2006-10-03 | Insignion Holding Limited | Composition and its therapeutic use |
| EP1768669B1 (en) * | 2004-07-19 | 2009-11-11 | Institut de Recherche pour le Développement ( IRD) | Pharmaceutical compositions for the treatment of leishmaniasis |
| US8273553B2 (en) * | 2004-11-02 | 2012-09-25 | Ares Trading S.A. | Production of growth hormone in serum-free cell culture medium for mammalian cells |
| KR101196103B1 (ko) | 2004-11-02 | 2012-11-01 | 아레스 트레이딩 에스.에이. | 포유동물 세포용 무?혈청 세포 배양 배지 |
| HUE038947T2 (hu) | 2005-08-26 | 2018-12-28 | Ares Trading Sa | Eljárás glikozilált béta-interferon elõállítására |
| US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
| SG10201510384UA (en) | 2006-09-13 | 2016-01-28 | Abbvie Inc | Cell culture improvements |
| WO2010048192A2 (en) | 2008-10-20 | 2010-04-29 | Abbott Laboratories | Viral inactivation during purification of antibodies |
| MX2011004200A (es) * | 2008-10-20 | 2011-05-24 | Abbott Lab | Aislamento y purificacion de anticuerpos usando la cromatografia de afinidad de proteina a. |
| US9062106B2 (en) | 2011-04-27 | 2015-06-23 | Abbvie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| BR112014000522B1 (pt) * | 2011-07-12 | 2021-03-23 | Foodchek Systems, Inc. | Meio de cultura e método para cultivar salmonella e e. coli |
| WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
| US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| BR112015004467A2 (pt) | 2012-09-02 | 2017-03-21 | Abbvie Inc | método para controlar a heterogeneidade de proteínas |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| EP2767273A1 (en) | 2013-02-15 | 2014-08-20 | Universitätsklinikum Erlangen | Death-associated protein kinases, inhibitors and activators thereof for use in pharmaceutical compositions and in predictive medicine |
| AU2013381687A1 (en) | 2013-03-12 | 2015-09-24 | Abbvie Inc. | Human antibodies that bind human TNF-alpha and methods of preparing the same |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
| WO2015051293A2 (en) | 2013-10-04 | 2015-04-09 | Abbvie, Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| EP3352586A4 (en) * | 2015-09-21 | 2019-05-15 | The Board Of Trustees Of The Leland Stanford Junior University | NUTRITIONAL ANTICANCER TREATMENT |
| JP6563145B2 (ja) * | 2017-08-09 | 2019-08-21 | 株式会社マンダム | 不死化汗腺筋上皮細胞 |
| EP3723772A4 (en) | 2017-12-11 | 2021-09-08 | Filtricine, Inc. | COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR THE TREATMENT OF CANCER AND METABOLIC INTERVENTION THERAPY |
| CN111172114B (zh) * | 2019-12-10 | 2021-11-30 | 上海中医药大学附属岳阳中西医结合医院 | 一种人源化肠癌前病变永生化上皮细胞系、构建方法及其应用 |
| CN114891722A (zh) * | 2022-05-13 | 2022-08-12 | 广东省农业科学院动物卫生研究所 | 禽肠道上皮细胞及其制备方法和应用 |
| CN116083342A (zh) * | 2023-01-16 | 2023-05-09 | 细新(上海)医疗科技有限公司 | 一种原代上皮细胞的培养体系和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4229531A (en) * | 1978-12-29 | 1980-10-21 | Monsanto Company | Production of tumor angiogenesis factor by cell culture |
| DE3711699A1 (de) * | 1987-04-07 | 1988-11-10 | Fraunhofer Ges Forschung | Medium zur kultivierung und proliferation von epithelialen zelltypen |
| US4885238A (en) * | 1987-10-30 | 1989-12-05 | The United States Of America As Represented By The Department Of Health And Human Services | Immortalized human bronchial epitherial mesothelial cell lines |
| AU2921289A (en) * | 1987-12-09 | 1989-07-19 | Invitron Corporation | Human cell life extension |
| US5093259A (en) * | 1988-07-07 | 1992-03-03 | Oak Ridge Associated Universities, Inc. | Continuous cell-line tamarin adenocarcinoma of the colon |
| US5665589A (en) * | 1988-12-14 | 1997-09-09 | The United States Of America As Represented By The Department Of Health And Human Services | Human liver epithelial cell lines |
| US5529920A (en) * | 1988-12-14 | 1996-06-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Human liver epithelial cell line and culture media therefor |
| US5376542A (en) | 1992-04-27 | 1994-12-27 | Georgetown University | Method for producing immortalized cell lines using human papilluma virus genes |
| DK0768375T4 (da) | 1992-07-06 | 2002-09-16 | Nestle Sa | Mælkesyrebakterier |
| US5462870A (en) * | 1993-04-23 | 1995-10-31 | Wayne State University | Human diploid salivary gland epithelial cell lines |
| US5672498A (en) * | 1993-12-28 | 1997-09-30 | The Gillete Company | Human corneal epithelial cell lines with extended lifespan |
| US5610043A (en) * | 1994-04-28 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus |
| EP0802257B1 (fr) * | 1996-04-19 | 2002-08-21 | Societe Des Produits Nestle S.A. | Lignée immortalisée de cellules épithéliales du colon humain |
-
1996
- 1996-04-19 EP EP96201064A patent/EP0802257B1/fr not_active Expired - Lifetime
- 1996-04-19 DK DK96201064T patent/DK0802257T3/da active
- 1996-04-19 PT PT96201064T patent/PT802257E/pt unknown
- 1996-04-19 DE DE69623109T patent/DE69623109T2/de not_active Expired - Lifetime
- 1996-04-19 ES ES96201064T patent/ES2180689T3/es not_active Expired - Lifetime
- 1996-04-19 AT AT96201064T patent/ATE222598T1/de active
-
1997
- 1997-04-16 NZ NZ314614A patent/NZ314614A/en not_active IP Right Cessation
- 1997-04-16 CA CA002202923A patent/CA2202923C/en not_active Expired - Fee Related
- 1997-04-16 RU RU97106170/13A patent/RU2220201C2/ru not_active IP Right Cessation
- 1997-04-17 AU AU18933/97A patent/AU733913B2/en not_active Ceased
- 1997-04-17 FI FI971628A patent/FI120352B/fi not_active IP Right Cessation
- 1997-04-17 NO NO19971757A patent/NO319494B1/no not_active IP Right Cessation
- 1997-04-17 US US08/839,271 patent/US6194203B1/en not_active Expired - Lifetime
- 1997-04-18 JP JP10217297A patent/JP3931212B2/ja not_active Expired - Fee Related
-
2000
- 2000-06-14 US US09/593,135 patent/US6399381B1/en not_active Expired - Lifetime
- 2000-06-14 US US09/593,134 patent/US6395542B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69623109T2 (de) | 2002-12-12 |
| US6194203B1 (en) | 2001-02-27 |
| US6399381B1 (en) | 2002-06-04 |
| ATE222598T1 (de) | 2002-09-15 |
| AU733913B2 (en) | 2001-05-31 |
| AU1893397A (en) | 1997-10-23 |
| CA2202923A1 (en) | 1997-10-19 |
| JPH1028580A (ja) | 1998-02-03 |
| EP0802257B1 (fr) | 2002-08-21 |
| NO971757L (no) | 1997-10-20 |
| US6395542B1 (en) | 2002-05-28 |
| EP0802257A1 (fr) | 1997-10-22 |
| RU2220201C2 (ru) | 2003-12-27 |
| CA2202923C (en) | 2008-06-10 |
| NO971757D0 (no) | 1997-04-17 |
| FI971628A (fi) | 1997-10-20 |
| DK0802257T3 (da) | 2002-10-28 |
| NO319494B1 (no) | 2005-08-22 |
| FI971628A0 (fi) | 1997-04-17 |
| NZ314614A (en) | 1999-04-29 |
| FI120352B (fi) | 2009-09-30 |
| DE69623109D1 (de) | 2002-09-26 |
| PT802257E (pt) | 2003-01-31 |
| JP3931212B2 (ja) | 2007-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2180689T3 (es) | Linea inmortalizada de celulas epiteliales del colon humano. | |
| Kim et al. | An in vitro intestinal platform with a self-sustaining oxygen gradient to study the human gut/microbiome interface | |
| Brun et al. | Helium generated cold plasma finely regulates activation of human fibroblast-like primary cells | |
| Rodrigues et al. | Arrabidaea chica hexanic extract induces mitochondrion damage and peptidase inhibition on Leishmania spp. | |
| Töpfer et al. | Bovine colon organoids: from 3D bioprinting to cryopreserved multi-well screening platforms | |
| Zugic et al. | Evaluation of anticancer and antioxidant activity of a commercially available CO2 supercritical extract of old man’s beard (Usnea barbata) | |
| Conti et al. | Biology of budding bacteria III. Fine structure of Rhodomicrobium and Hyphomicrobium spp | |
| Jobeili et al. | Selenium preserves keratinocyte stemness and delays senescence by maintaining epidermal adhesion | |
| DK6081A (da) | Fremgangsmaade til fremstilling af et bakteriepraeparat | |
| NO20060982L (no) | Dispergerende formulering for et anti-inflammatorisk middel | |
| MXPA04009031A (es) | Celulas madre hepaticas primitivas y proximales. | |
| Ghosh et al. | Seasonal modulation of immunity by melatonin and gonadal steroids in a short day breeder goat Capra hircus | |
| ES2142864T3 (es) | Procedimiento y medio de cultivo para la obtencion de celulas infectadas por un virus asociado a la esclerosis en placas. | |
| Wang et al. | The antioxidant from ethanolic extract of Rosa cymosa fruits activates phosphatase and tensin homolog in vitro and in vivo: A new insight on its antileukemic effect | |
| An et al. | In vitro antioxidant activities of Rhodobacter sphaeroides and protective effect on Caco-2 cell line model | |
| Cedikova et al. | Effects of the czech propolis on sperm mitochondrial function | |
| DE60140051D1 (de) | Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen | |
| Stanley et al. | Pressure-induced cellular senescence: A mechanism linking venous hypertension to venous ulcers1 | |
| Arrais-Silva et al. | Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes | |
| ATE15693T1 (de) | Zellkultur-verfahren. | |
| AU4751797A (en) | Defined systems for epithelial cell culture and use thereof | |
| Zhang et al. | Isolation, culture, and identification of duck intestinal epithelial cells and oxidative stress model constructed | |
| SE9704590D0 (sv) | Method of increasing the production and improving the quality of semen | |
| AR115304A1 (es) | Células madre / progenitoras de las glándulas de brunner duodenales y métodos para su aislamiento y uso | |
| López et al. | Cytotoxic effects of Anagallis arvensis and Anagallis foemina in neuronal and colonic adenocarcinoma cell lines |